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Oxalate nephropathy is a rare but irreversible etiology for acute renal function impairment, and often
caused by poisoning, inﬂammatory bowel disease, excessive food ingestion, and surgery. Herein, we have
reported the case of a 65-year-old man with gallbladder cancer who developed progressive renal
function deterioration several months after Roux-en-Y surgery. The patient's renal biopsy showed oxa-
late nephropathy, and his renal function impairment eventually required long-term dialysis. Therefore,
oxalate nephropathy should be considered in patients with unexplained renal function impairment after
Roux-en-Y surgery.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute kidney injury in patients who are receiving anti-cancer
treatments is an uncommon but serious complication. Such
injury is often induced by nephrotoxic agents or urinary tract
obstruction by space-occupying lesions. Among the many possible
causes for renal function impairment in cancer patients, oxalate
nephropathy is a rare but irreversible etiology. Oxalate nephropa-
thy is associated with surgery, ethylene glycol poisoning, inﬂam-
matory bowel disease, or food ingestion.1 Nephrolithiasis,
nephrocalcinosis, progressive chronic kidney disease, and end-
stage kidney disease are the most common clinical presentations.
Herein, we report a 65-year old man with gallbladder cancer who
developed progressive renal function deterioration several months
after Roux-en-Y hepaticojejunostomy. Subsequently, oxalate ne-
phropathy was conﬁrmed by renal biopsy.
2. Case report
A 65-year-old man was diagnosed to have gallbladder cancer
with common bile duct invasion. In an effort to cure the underlying
cancer, the patient underwent cholecystectomy, hilar lymph nodegy and Medical Oncology,
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Society. Production and hosting bydissection and Roux-en Y hepaticojejunostomy. However, local
recurrence over the liver was later identiﬁed and he received a
partial hepatectomy six months thereafter. In all, the patient
received a total of 12 cycles of chemotherapy with cisplatin and 5-
FU after surgery. His serum creatinine at baseline was 1.07 mg/dL
(normal: 0.7e1.4). After the 12 cycles of chemotherapy were
completed, the patient's medical team fortuitously noted deterio-
rated renal function (serum creatinine: 5.69 mg/d). The patient
showed no signs of hematuria or proteinuria, but did have a history
of gouty arthritis. Abdominal ultrasonography revealed multiple
stones over the left kidney without hydronephrosis; the length of
the right and left kidneys was 9.5 and 9.1 cm, respectively. Initially,
platinum-associated renal function impairment was considered,
which halted additional chemotherapy. One month later, however,
his serum creatinine level had elevated to 14.77 mg/dL. A routine
urine test showed onlymild proteinuria and glucosuria, and arterial
blood gas analysis indicated metabolic acidosis. Hyperuricemia
(12.8 mg/dL; normal: 2.4e7.2 mg/dL) was also noted. Immunolog-
ical examinations showed negative ANA, ANCA, and anti-GBM
antibody which essentially excluded the possibility of Good-
pasture's disease and vasculitis associated renal function impair-
ment. Thereafter, a renal biopsy was performed on the patient due
to his unexplained acute kidney injury. The histological examina-
tion showed oxalate crystal deposition over the tubular lumina,
resulting in tubular dilation, tubular cell injury and focal tubular
basement membrane destruction (Fig. 1). Besides, increased
leukocyte inﬁltration, composed of mononuclear cells, and a smallElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. (A) H&E stain revealed oxalate crystal deposition (arrow) and tubular dilatation
with tubular basement membrane destruction (arrow head). (B) Oxalate crystal was
detected under polariscope.
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over the interstitium. This pathological presentationwas consistent
with oxalate nephropathy. This patient denied a history of ethylene
glycol ingestion, excessive dietary ingestion, or high vitamin C
intake. Thereafter, he initiated regular hemodialysis because of
irreversible renal function impairment.
3. Discussion
Oxalate is an endogenous end product of amino acid meta-
bolism absorbed by the gastrointestinal tract and excreted in the
urine.2 Increased absorption of oxalate attributable to inﬂamma-
tory bowel disease, ileal resection, bariatric surgery, Averrhoa
carambola (star fruit), Averrhoa bilimbi (cucumber tree fruit),
rhubarb, peanuts and black tea are the possible causes of enteric
hyperoxaluria.3 Additionally, increased intestinal absorption of
oxalate due to malabsorption is the pathophysiology of hyper-
oxaluria in patients with non-excessive ingestion. Hyperoxaluriadue to malabsorption of fatty acid also could be caused by a deﬁ-
ciency of pyridoxine or vitamin B6, leading to the accumulation of
peroxisomal glyoxylate which oxidizes to oxalate in the liver.4
Roux-en-Y gastric bypass surgery is a common cause of malab-
sorption associated with hyperoxaluria in obese patients and those
with malignancies. Postoperatively, patients may have steatorrhea,
weight loss, and diarrhea, resulting in malabsorption syndrome,
whichwould increase excessive intraluminal free fatty acid and bile
salt. In the physiological condition, the oxalate would bind with
calcium and be excreted in the stool. With the binding of calcium
and fatty acid, it would cause further excessive absorption of oxa-
late from the gut. Additionally, it may further cause nephrolithiasis
and nephrocalcinosis.5 One study indicated that obese patients
who have undergone Roux-en-Y bypass surgery have a signiﬁcantly
higher incidence of nephrolithiasis compared to those in the con-
trol group (7.6 versus 4.6%, P < 0.0001).6 Similarly, patients with
malignancies also have signiﬁcantly higher postoperative neph-
rolithiasis and renal dysfunction after Roux-en-Y reconstruction
surgery.5 Currently, effective treatments for hyperoxaluria are not
yet feasible. Chemotherapy-induced nephrotoxicity, but not other
etiologies, is usually considered to be the major cause of acute
kidney injury in patients receiving chemotherapeutic agents. In this
case, although an uncommon disease, oxalate nephropathy is the
etiology responsible for the acute kidney injury. It usually occurs
3e24 months after completion of the Roux-en-Y procedure,7 with
an outcome that is typically dismal. One study has suggested that
72.7% of patients with oxalate nephropathy progress to end-stage
kidney disease within 3 months.1
In conclusion, although oxalate nephropathy is a rare compli-
cation for patients receiving Rou-en-Y surgery, it should routinely
be taken into consideration in cases with unexplained acute kidney
injury deterioration after such surgery. Additionally, renal biopsy is
required for a deﬁnitive diagnosis, in order to effectively exclude
other possible etiologies for acute kidney injury. However, the
outcome of oxalate nephropathy is usually disappointing because
of its rapid progression to end-stage kidney disease. Ultimately,
because no effective treatments are currently available, substantial
further research is necessary to ﬁnd efﬁcacious ways to extend the
lives of patients with oxalate nephropathy.Conﬂict of interest
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